亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北帝鑫化工制造有限公司銷售總部  

醫藥原料及醫藥中間體

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:蘇健
  • 電話:027-50483962
  • 郵件:1691710457@qq.com
  • 傳真:027-67880826
  • QQ:1691710457
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 雙氯芬酸二乙胺誠信國字號廠家,專業原料基地
雙氯芬酸二乙胺誠信國字號廠家,專業原料基地
單價 100.00 / 公斤對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 5000公斤起訂1公斤
包裝 25公斤/桶
含量 98%
保質期 長期
過期 長期有效
更新 2014-11-12 09:05
 
詳細信息
 雙氯芬酸二乙胺
英文名稱:Diclofenac diethylamine
英文同義詞:DICLOFENAC DIETHYLAMINE;2-[2-(2,6-dichloroanilino)phenyl]acetic acid;n-ethylethanamine 2-[(2,6-dichlorophenyl)amino]benzeneacetate;2-[(2,6-dichlorophenyl)amino]-benzeneacetic acid *pd. with n-ethylethanamine;2-[(2,6-dichlorophenyl)amino]-benzeneacetic acid *pd. with n-ethylethanamine (1:1)
中文名稱:雙氯芬酸二乙胺
中文同義詞:雙氯芬酸二乙胺;雙氯芬酸二乙胺鹽;2-(2,6-二氯苯胺)***二乙胺鹽;2-((2,6-二氯苯基)氨基)***二乙胺鹽
CAS 號:78213-16-8
分子式:C18H22Cl2N2O2
分子量:369.29
含  量:≥99%
熔  點:145-148℃
性  狀:白色結晶性粉末
雙氯芬酸二乙胺鹽用途:肌肉和關節創傷性炎癥的局部治療,肌腱,韌帶,肌肉和關節創傷性炎癥的局部治療,如扭傷、勞損和挫傷。局限性軟組織風濕病,如腱鞘炎、肩手綜合征和滑囊炎。局限性風濕性疾病,如周圍關節和脊柱的骨關節病,關節周圍病變。
190
 
©2025 湖北帝鑫化工制造有限公司銷售總部 版權所有   技術支持:化工網   訪問量:25565  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |